1 – 11 of 11
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic
2024) In Infection(
- Contribution to journal › Article
-
Mark
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
2024) In Diabetologia(
- Contribution to journal › Article
-
Mark
Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes : A secondary analysis of the POInT Study
(
- Contribution to journal › Article
-
Mark
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes
2024) In Diabetes Care(
- Contribution to journal › Article
-
Mark
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
2024) In Diabetologia(
- Contribution to journal › Article
- 2023
-
Mark
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
(
- Contribution to journal › Article
- 2022
-
Mark
Elevations in blood glucose before and after the appearance of islet autoantibodies in children
(
- Contribution to journal › Article
- 2019
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
(
- Contribution to journal › Article
-
Mark
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD-02 study design and first results
(
- Contribution to journal › Article
- 2012
-
Mark
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus
(
- Contribution to journal › Article